- Home
- TLSI vs SPCE Comparison
TLSI vs SPCE Comparison
Compare TLSI & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- SPCE
- Stock Information
- Founded
- TLSI 2010
- SPCE 2017
- Country
- TLSI United States
- SPCE United States
- Employees
- TLSI N/A
- SPCE N/A
- Industry
- TLSI Medical Specialities
- SPCE Transportation Services
- Sector
- TLSI Health Care
- SPCE Consumer Discretionary
- Exchange
- TLSI Nasdaq
- SPCE Nasdaq
- Market Cap
- TLSI 124.9M
- SPCE 187.1M
- IPO Year
- TLSI N/A
- SPCE N/A
- Fundamental
- Price
- TLSI $4.69
- SPCE $5.32
- Analyst Decision
- TLSI Strong Buy
- SPCE Hold
- Analyst Count
- TLSI 6
- SPCE 6
- Target Price
- TLSI $11.75
- SPCE $25.50
- AVG Volume (30 Days)
- TLSI 36.4K
- SPCE 1.7M
- Earning Date
- TLSI 11-14-2024
- SPCE 02-25-2025
- Dividend Yield
- TLSI N/A
- SPCE N/A
- EPS Growth
- TLSI N/A
- SPCE N/A
- EPS
- TLSI N/A
- SPCE N/A
- Revenue
- TLSI $26,891,000.00
- SPCE $9,416,000.00
- Revenue This Year
- TLSI $60.96
- SPCE $5.88
- Revenue Next Year
- TLSI $53.65
- SPCE N/A
- P/E Ratio
- TLSI N/A
- SPCE N/A
- Revenue Growth
- TLSI 67.90
- SPCE 93.74
- 52 Week Low
- TLSI $3.50
- SPCE $5.23
- 52 Week High
- TLSI $10.42
- SPCE $43.20
- Technical
- Relative Strength Index (RSI)
- TLSI 51.68
- SPCE 33.68
- Support Level
- TLSI $4.72
- SPCE $5.23
- Resistance Level
- TLSI $5.32
- SPCE $6.74
- Average True Range (ATR)
- TLSI 0.31
- SPCE 0.39
- MACD
- TLSI 0.01
- SPCE -0.07
- Stochastic Oscillator
- TLSI 47.52
- SPCE 5.83
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.